Literature DB >> 25739386

Double Stranded RNA-Dependent Protein Kinase is Necessary for TNF-α-Induced Osteoclast Formation In Vitro and In Vivo.

Hiroki Shinohara1,2, Jumpei Teramachi1, Hirohiko Okamura1, Di Yang1, Toshihiko Nagata2, Tatsuji Haneji1.   

Abstract

Double-stranded RNA-dependent protein kinase (PKR) is involved in cell cycle progression, cell proliferation, cell differentiation, tumorgenesis, and apoptosis. We previously reported that PKR is required for differentiation and calcification in osteoblasts. TNF-α plays a key role in osteoclast differentiation. However, it is unknown about the roles of PKR in the TNF-α-induced osteoclast differentiation. The expression of PKR in osteoclast precursor RAW264.7 cells increased during TNF-α-induced osteoclastogenesis. The TNF-α-induced osteoclast differentiation in bone marrow-derived macrophages and RAW264.7 cells was markedly suppressed by the pretreatment of PKR inhibitor, 2-aminopurine (2AP), as well as gene silencing of PKR. The expression of gene markers in the differentiated osteoclasts including TRAP, Calcitonin receptor, cathepsin K, and ATP6V0d2 was also suppressed by the 2AP treatment. Bone resorption activity of TNF-α-induced osteoclasts was also supressed by 2AP treatment. Inhibition of PKR supressed the TNF-α-induced activation of NF-κB and MAPK in RAW264.7 cells. 2AP inhibited both the nuclear translocation of NF-κB and its transcriptional activity in RAW264.7 cells. 2AP inhibited the TNF-α-induced expression of NFATc1 and c-fos, master transcription factors in osteoclastogenesis. TNF-α-induced nuclear translocation of NFATc1 in mature osteoclasts was clearly inhibited by the 2AP treatment. The PKR inhibitor C16 decreased the TNF-α-induced osteoclast formation and bone resorption in mouse calvaria. The present study indicates that PKR is necessary for the TNF-α-induced osteoclast differentiation in vitro and in vivo.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  MAPK; NF-κB; OSTEOCLAST; PKR; RAW264.7; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 25739386     DOI: 10.1002/jcb.25151

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.

Authors:  Hirofumi Tenshin; Jumpei Teramachi; Asuka Oda; Ryota Amachi; Masahiro Hiasa; Ariunzaya Bat-Erdene; Keiichiro Watanabe; Masami Iwasa; Takeshi Harada; Shiro Fujii; Kumiko Kagawa; Kimiko Sogabe; Shingen Nakamura; Hirokazu Miki; Kiyoe Kurahashi; Sumiko Yoshida; Kenichi Aihara; Itsuro Endo; Eiji Tanaka; Toshio Matsumoto; Masahiro Abe
Journal:  Blood Adv       Date:  2017-10-26

2.  Inhibition of PKR protects against H2O2-induced injury on neonatal cardiac myocytes by attenuating apoptosis and inflammation.

Authors:  Yongyi Wang; Min Men; Bo Xie; Jianggui Shan; Chengxi Wang; Jidong Liu; Hui Zheng; Wengang Yang; Song Xue; Changfa Guo
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

3.  Interleukin-37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction.

Authors:  Ruohui Tang; Jin Yi; Jing Yang; Yueqi Chen; Wei Luo; Shiwu Dong; Jun Fei
Journal:  J Cell Physiol       Date:  2018-11-10       Impact factor: 6.384

Review 4.  Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli.

Authors:  Lingbo Kong; Wanli Smith; Dingjun Hao
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

5.  Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.

Authors:  You-Jung Ha; Yong Seok Choi; Ye Rim Oh; Eun Ha Kang; Gilson Khang; Yong-Beom Park; Yun Jong Lee
Journal:  Mar Drugs       Date:  2021-02-27       Impact factor: 5.118

6.  TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression.

Authors:  Hirofumi Tenshin; Jumpei Teramachi; Mohannad Ashtar; Masahiro Hiasa; Yusuke Inoue; Asuka Oda; Kotaro Tanimoto; So Shimizu; Yoshiki Higa; Takeshi Harada; Masahiro Oura; Kimiko Sogabe; Tomoyo Hara; Ryohei Sumitani; Tomoko Maruhashi; Mayu Sebe; Rie Tsutsumi; Hiroshi Sakaue; Itsuro Endo; Toshio Matsumoto; Eiji Tanaka; Masahiro Abe
Journal:  Clin Transl Immunology       Date:  2022-01-19

Review 7.  Mucosal immunity and tRNA, tRF, and tiRNA.

Authors:  Yueying Chen; Jun Shen
Journal:  J Mol Med (Berl)       Date:  2020-11-16       Impact factor: 4.599

8.  The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.

Authors:  Mohannad Ashtar; Hirofumi Tenshin; Jumpei Teramachi; Ariunzaya Bat-Erdene; Masahiro Hiasa; Asuka Oda; Kotaro Tanimoto; So Shimizu; Yoshiki Higa; Takeshi Harada; Masahiro Oura; Kimiko Sogabe; Shingen Nakamura; Shiro Fujii; Ryohei Sumitani; Hirokazu Miki; Kengo Udaka; Mamiko Takahashi; Kumiko Kagawa; Itsuro Endo; Eiji Tanaka; Toshio Matsumoto; Masahiro Abe
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

9.  Cell fate determined by the activation balance between PKR and SPHK1.

Authors:  Han Qiao; Tianqing Jiang; Peiqiang Mu; Xiaoxuan Chen; Xianhui Wen; Zhangsheng Hu; Shulin Tang; Jikai Wen; Yiqun Deng
Journal:  Cell Death Differ       Date:  2020-08-15       Impact factor: 15.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.